Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. BELLUS Health Inc (BLU)
  7. News

BLU

BELLUS Health Inc
8.23
0.42 (5.38%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
BELLUS Health Inc BLU NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.42 5.38% 8.23 17:08:09
Open Price Low Price High Price Close Price Prev Close
7.80 7.79 8.255 8.23 7.81
more quote information »

Recent News

Date Time Source Heading
2/07/20239:17IHNWFeaturedAmerican Green (OTC:ERBB) Signs $12 Million Dollar Non-Binding Letter of Intent for Funding of its Cypress Chill Cannabis Grow Facility PHOENIX, AZ (January 7,
2/07/20237:00IHNWFeaturedGoldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone
11/14/202217:47EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/14/202216:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/14/202216:01BWBELLUS Santé annonce ses résultats financiers et faits..
11/10/202216:03EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/10/202216:01BWBELLUS Santé participera prochainement à deux conférences..
10/11/202207:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/10/202207:00BWBELLUS Health to Present Clinical Data from Phase 2b SOOTHE..
9/06/202207:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/06/202207:00BWBELLUS Health to Present at the H.C. Wainwright Global..
8/26/202216:51EDGARRegistration Statement for Securities of Certain Canadian..
8/22/202207:00BWBELLUS Health to Present Clinical Data from Phase 2b SOOTHE..
8/10/202216:32EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
8/10/202216:30BWBELLUS Health Reports Second Quarter 2022 Financial Results..
7/18/202216:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/18/202213:38BWBELLUS Health Closes US$153 Million Public Offering of..
7/15/202207:04EDGARVoluntary Supplemental Material Filed Pursuant to Section..
7/14/202216:47EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/13/202221:57BWBELLUS Health Announces Pricing of US$153 Million Public..
7/13/202217:02EDGARVoluntary Supplemental Material Filed Pursuant to Section..
7/13/202216:26EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/13/202216:01BWBELLUS Santé annonce le lancement d’un placement public..
7/12/202207:28EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/12/202207:00BWBellus Health Announces Positive End-of-Phase 2 Meeting with..
7/05/202207:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/05/202207:00BWBELLUS Santé participera à la William Blair Biotech Focus..
6/01/202207:00BWBELLUS Health to Participate in the Jefferies Healthcare..
5/11/202216:50BWBELLUS Santé annonce ses résultats financiers et faits..
4/25/202216:03EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/19/202216:14EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/04/202211:33EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/23/202217:25EDGARAnnual Report (foreign Private Issuer) (40-f)
2/14/202218:18EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202216:08EDGARStatement of Ownership (sc 13g)
2/14/202210:59EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202208:04EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202216:27EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202206:40EDGARAmended Statement of Ownership (sc 13g/a)